· Transaction also includes Pharmatec subsidiary Schoeller-Bleckmann Medizintechnik

· Anti-trust authorities grant unqualified approval

STUTTGART – The Bosch Group has acquired Pharmatec GmbH, based in Dresden, Germany, from Fresenius ProServe GmbH. The transaction includes the acquisition of Pharmatec subsidiary Schoeller-Bleckmann Medizintechnik Ges.m.b.H, based in Ternitz, Austria.
This acquisition has been given unqualified approval by the anti-trust authorities. Pharmatec is a leading company in pharmaceutical plant engineering, specializing in hygienic and sterile process technologies, in particular in the areas of pharma and biotechnology.

In fiscal 2006, Pharmatec GmbH and its around 160 associates generated sales of approximately 30 million euros. "Pharmatec and Schoeller-Bleckmann Medizintechnik are both recognized specialists, and the two companies will excellently complement our existing product range in the pharma packaging technology sector," said Friedbert Klefenz, president of the Bosch Packaging Technology division. It has been agreed that the purchase price will not be disclosed.

The Packaging Technology division develops, manufactures, and markets Bosch process and packaging machines and lines for the confectionery, food, and luxury food sectors, as well as for the pharmaceutical industry. In 2006, the division, with a workforce of around 3,780 associates, generated global sales of approximately 570 million euros.

The Bosch Group is a leading global supplier of technology and services. In the areas of automotive and industrial technology, consumer goods, and building technology, some 275,000 associates generated sales of 38.2 billion euros in fiscal 2009. The Bosch Group comprises Robert Bosch GmbH and its more than 300 subsidiaries and regional companies in over 60 countries. If its sales and service partners are included, then Bosch is represented in roughly 150 countries. This worldwide development, manufacturing, and sales network is the foundation for growth. Each year, Bosch spends more than 3.5 billion euros for research and development, and applies for some 3,800 patents worldwide. With all its products and services, Bosch enhances the quality of life by providing solutions which are both innovative and beneficial. The company was set up in Stuttgart in 1886 by Robert Bosch (1861-1942) as “Workshop for Precision Mechanics and Electrical Engineering.” The special ownership structure of Robert Bosch GmbH guarantees the entrepreneurial freedom of the Bosch Group, making it possible for the company to plan over the long term and to undertake significant up-front investments in the safeguarding of its future. Ninety-two percent of the share capital of Robert Bosch GmbH is held by Robert Bosch Stiftung GmbH, a charitable foundation. The majority of voting rights are held by Robert Bosch Industrietreuhand KG, an industrial trust. The entrepreneurial ownership functions are carried out by the trust. The remaining shares are held by the Bosch family and by Robert Bosch GmbH. Additional information can be accessed at www.bosch.com.

PI5914 - July 09, 2007